Search
for
Sort by
Research 31–60 of 38
- Under Development JAK Inhibitors for Dermatologic Diseases
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Progress in the Use of Platelet-rich Plasma in Aesthetic and Medical Dermatology.
- 567 Acute generalized exanthematous pustulosis (AGEP) induced by plaquenil
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- Common Skin Diseases and Metabolic Syndrome: A Proinflammatory Chemokine Perspective
- Inflammatory Skin Disease in Latin America: Treatment Challenges and Opportunities
- Review of Promising Off-Label Use of Deucravacitinib
- 44047 Long Term Real-World Treat-to-Target Skin Clearance and Maintenance of Response with Risankizumab in Patients with Moderate to Severe Psoriasis From the CorEvitas Psoriasis Registry
- Generalized hypertrichosis due to secukinumab in a patient with moderate psoriasis: A case of serendipity or zemblanity?
- Ixekizumab shows efficacy and safety in patients who failed biweekly etanercept therapy: Analysis From UNCOVER-2, a phase 3 randomized clinical trial in psoriasis
- Real-world single-center experience with 10 cases of generalized pustular psoriasis successfully treated with ixekizumab
- Dermoscopy of an osteonevus of Nanta
- Ixekizumab Improved Refractory Erythrodermic Psoriasis with Comorbid Diffuse Alopecia: A Case Report with 52-Week Follow-Up
- Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Interventions for nail psoriasis
- The role of diet in the management of psoriasis: a scoping review
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Disease severity scoring systems in dermatology
- Semaglutide and the Skin: An Overview of Current Evidence
- Dermatologia e Procedimentos Estéticos Ed. XVIII
- Advances in dermatology research: A comprehensive literature review
- Psoriasis del cuero cabelludo etiología, diagnóstico y tratamiento
- Treating Psoriasis: What Is New About Fumaric Acid Esters?
- Abstracts from the 17th Congress of the European Society for Dermatology and Psychiatry
- 265 Modulation of disease-central cytokine pathways with TAK-279, a highly selective oral tyrosine kinase 2 (TYK2) inhibitor, defines clinical response in patients with psoriasis
- Can Platelet-Rich Plasma Reduce the Burden of Inflammatory Skin Diseases Such as Psoriasis and Atopic Dermatitis?
- CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway